Structure Therapeutics Inc. SEC filings GPCR
Structure Therapeutics Inc. has 271 filings in SEC EDGAR's recent list, going back to Oct 21, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | May 7, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| 424B5 | Prospectus supplement | Dec 8, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 6, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 424B4 | Prospectus | Jun 6, 2024 | — |
| S-1MEF | Filing | Jun 5, 2024 | — |
| S-1 | Registration statement | Jun 3, 2024 | — |
| S-8 | Employee stock plan registration | Mar 8, 2024 | — |
| S-1 | Registration statement | Nov 17, 2023 | — |
| S-8 | Employee stock plan registration | Feb 6, 2023 | — |
| 424B4 | Prospectus | Feb 6, 2023 | — |
| S-1MEF | Form s-1mef | Feb 2, 2023 | — |
| S-1/A | Amended registration statement | Jan 30, 2023 | — |
| F-6 | Filing | Jan 30, 2023 | — |
| S-1 | Registration statement | Jan 12, 2023 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GPCR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- South San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1888886
- Former names
- ShouTi Inc. (until May 13, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.